NYC Health + Hospitals/Bellevue announced on June 9, 2026, that its cardiovascular team successfully completed the 200th Transcatheter Aortic Valve Replacement (TAVR) procedure.
Before the procedure could occur, the Bellevue Heart Team identified a significant anatomical hurdle.
The program’s ability to move from a pilot phase to a high-volume center reflects a systemic investment in specialized equipment and staff training.
Technical Complexity and the Use of the BASILICA Technique One of the most technically demanding aspects of the 200th case was the requirement for the BASILICA technique.
For a facility like Bellevue, which manages over 100,000 emergency room visits and half a million outpatient visits annually, bed turnaround is a critical metric.
Bellevue Hospital reaches its 200th TAVR procedure, expanding access to life-saving heart care for New York City’s most vulnerable patient populations.